ExlService Holdings, Inc. (NASDAQ:EXLS)
| Market Cap | 5.38B-16.4% |
| Revenue (ttm) | 2.24B+13.6% |
| Net Income | 250.00M+5.8% |
| EPS | 1.59+10.4% |
| Shares Out | 151.61M |
| PE Ratio | 22.33 |
| Forward PE | 13.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,469,296 |
| Open | 35.43 |
| Previous Close | 35.41 |
| Day's Range | 35.37 - 35.75 |
| 52-Week Range | 24.85 - 43.88 |
| Beta | 0.84 |
| Analysts | Buy |
| Price Target | 44.00(+23.91%) |
| Earnings Date | Oct 27, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About EXLS
ExlService Holdings, Inc. functions as a global provider of data analytics, digital operational solutions, and comprehensive services, operating across the United States and internationally. The company organizes its operations into distinct segments: Insurance, Healthcare, Analytics, and Emerging Business. For the insurance sector, EXL delivers a suite of digital transformation and analytics-driven services. These offerings span a wide array of functions, including streamlined claims processing, administration of premiums and benefits, agency oversight, account reconciliation, policy research, underwriting assistance, new client acquisition, policy servicing, premium audits, various surveys (including commercial and residential), invoicing and collections, and enhanced customer support. These services are powered by cutting-edge digital technologies, artificial intelligence, machine learning, and sophisticated automation. Furthermore, EXL facilitates digital customer acquisition through a Software-as-a-Service (SaaS) model via its LifePRO and LISS platforms, and also provides subrogation services, including its comprehensive Subrosource software platform. In the healthcare domain, EXL presents CareRadius, an integrated care management system. It delivers diverse healthcare services such as care management, utilization review, disease management, payment accuracy, revenue enhancement, and customer interaction strategies for healthcare payers, service providers, pharmacy benefit management companies, and life sciences entities. Beyond these industry-specific services, EXL specializes in advanced predictive and prescriptive analytical capabilities. These are applied to critical areas like customer acquisition and lifecycle navigation, risk assessment and pricing, optimizing operational efficiency, oversight of credit and operational risks, ensuring payment accuracy and care coordination, and comprehensive data governance. Established in 1999, ExlService Holdings, Inc. maintains its corporate headquarters in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$EXLS stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of EXLS by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Mar 31, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Mar 31, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Mar 30, 2020 |
Recently reported changes in EXLS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EXLS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EXLS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EXLS Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Revenues, net | $594.76M | 27.62% |
| Data and AI-Led | $362.56M | 16.84% |
| Employee costs | $300.88M | 13.97% |
| Insurance | $233.70M | 10.85% |
| Digital operations | $232.21M | 10.78% |
| Banking, Capital Markets and Diversified Industries | $202.81M | 9.42% |
| Healthcare and Life Sciences | $158.26M | 7.35% |
| Infrastructure and technology costs | $43.69M | 2.03% |
| Other costs | $24.23M | 1.13% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EXLS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EXLS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in EXLS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $176.02M |
| VBVanguard Morningstar Small-Cap ETF | $127.24M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $73.04M |
| VXFVanguard Extended Market ETF | $67.61M |
| XMHQInvesco S&P MidCap Quality ETF | $44.82M |
| DFASDimensional - US Small Cap ETF | $43.11M |
Estimated from each fund’s disclosed top holdings × AUM
EXLS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EXLS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score